Liposome-Encapsulated Hemoglobin Ameliorates Tumor Hypoxia and Enhances Radiation Therapy to Suppress Tumor Growth in Mice

Artificial Organs

Volumn 36, Issue 2, 2012, Pages 170-177

  Murayama, Chieko ^a   Kawaguchi, Akira T ^a   Ishikawa, Kenji ^a   Kamijo, Akemi ^a   Kato, Nobusuke ^a   Ohizumi, Yukio ^a   Sadahiro, Sotaro ^a   Haida, Munetaka ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Hypoxia inducible factor 1 ; Liposome encapsulated hemoglobin; Oxygen; Radiotherapy; Tumor growth delay; Tumor hypoxia

Indexed keywords

HEMOGLOBIN; MAMMALS; RADIATION; RADIOTHERAPY; TUMORS;

GROWTH SUPPRESSIONS; HYPOXIA-INDUCIBLE FACTOR-1Α; HYPOXIA-INDUCIBLE FACTORS; LIPOSOME ENCAPSULATED HEMOGLOBINS; OPTIMAL TIMING; TIME POINTS; TUMOR GROWTH; TUMOR GROWTH DELAY; TUMOR HYPOXIA; TUMOR SIZE;

OXYGEN;

HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOSOME; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREATHING; CANCER INHIBITION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

MUS;

EID: 84857083184     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01418.x     Document Type: Article

References (26)

1. Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 2004;381:335-54.
2. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39.
3. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6:10-21.
4. Murayama C, Suzuki A, Sato C, etal. Radiosensitization by a new potent nucleoside analog: 1-(1′, 3′, 4′-trihydroxy-2′-butoxy) methyl-2-nitroimidazole (PR-350). Int J Radiat Oncol Biol Phys 1993;26:433-43.
5. Teicher BA, Rose CM. Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice. Cancer Res 1984;44:4285-8.
6. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Cancer Res 1987;47:442-6.
7. Teicher BA, Ara G, Chen YN, etal. PEG-hemoglobin: effects on tumor oxygenation and radiosensitization. Radiat Oncol Invest 1996;4:200-10.
8. Masunaga S, Nagasawa H, Uto Y, etal. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Int J Hyperthermia 2005;21:305-18.
9. Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007;25:4066-74.
10. Nosé Y. Is there a role for blood substitutes in civilian medicine: a drug for emergency shock cases? Artif Organs 2004;28:807-12.
11. Yu M, Dai M, Liu Q, etal. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back. Cancer Treat Rev 2007;33:757-61.
12. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. A meta-analysis. JAMA 2008;299:2304-12.
13. Kaneda S, Ishizuka T, Goto H, etal. Liposome-encapsulated hemoglobin, TRM-645: current status of the development and important issues for clinical application. Artif Organs 2009;33:146-52.
14. Kawaguchi AT, Fukumoto D, Haida M, etal. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat. Evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke 2007;38:1626-32.
15. Kawaguchi AT, Kurita D, Furuya H, etal. Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in the rat. Artif Organs 2009;33:153-8.
16. Kawaguchi AT, Haida M, Yamano M, etal. Liposome-encapsulated hemoglobin ameliorates ischemic stroke in nonhuman primates: an acute study. J Pharmacol Exp Ther 2010;332:429-36.
17. Okada M, Kawaguchi AT, Hakuba S, etal. Liposome-encapsulated hemoglobin alleviates hearing loss after transient cochlear ischemia and reperfusion in the gerbil. Artif Organs 2012;36:178-84.
18. Fukui T, Kawaguchi AT, Tanaka R, etal. Liposome-encapsulated hemoglobin ameliorates skin wound healing in mice. Artif Organs 2012;36:161-9.
19. Raleigh JA, Chou SC, Arteel GE, etal. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 1999;151:580-9.
20. Mayer A, Hockel M, Vaupel P. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther Onkol 2006;182:501-10.
21. Lee K, Roth RA, LaPres JJ. Hypoxia, drug therapy and toxicity. Pharmacol Ther 2007;113:229-46.
22. Chaplin DJ, Olive PL, Durand RE. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 1987;47:597-601.
23. Matsumoto S, Yasui H, Mitchell JB, etal. Imaging cycling tumor hypoxia. Cancer Res 2010;70:10019-23.
24. Shibamoto Y, Sasai K, Abe M. The radiation response of SCCVII tumor cells in C3H/He mice varies with the irradiation conditions. Radiat Res 1987;109:352-4.
25. Murata R, Shibamoto Y, Sasai K, etal. Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int J Radiat Oncol Biol Phys 1996;34:859-65.
26. Chaplin DJ, Horsman MR, Trotter MJ. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst 1990;82:672-6.